China Dongsheng International Competitors

Acusphere (OTCMKTS:ACUS) and China Dongsheng International (OTCMKTS:CDSG) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, dividends, earnings and risk.

Profitability

This table compares Acusphere and China Dongsheng International's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of recent recommendations and price targets for Acusphere and China Dongsheng International, as provided by MarketBeat.com.

Risk and Volatility

Acusphere has a beta of -0.25, meaning that its share price is 125% less volatile than the S&P 500. Comparatively, China Dongsheng International has a beta of 13.38, meaning that its share price is 1,238% more volatile than the S&P 500.

Earnings and Valuation

This table compares Acusphere and China Dongsheng International's gross revenue, earnings per share and valuation.

Summary

China Dongsheng International beats Acusphere on 1 of the 1 factors compared between the two stocks.

China Dongsheng International (OTCMKTS:CDSG) and Affymax (OTCMKTS:AFFY) are both consumer staples companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, profitability, institutional ownership, valuation, dividends, analyst recommendations and risk.

Profitability

This table compares China Dongsheng International and Affymax's net margins, return on equity and return on assets.

Valuation and Earnings

This table compares China Dongsheng International and Affymax's top-line revenue, earnings per share (EPS) and valuation.

Analyst Recommendations

This is a breakdown of recent ratings for China Dongsheng International and Affymax, as reported by MarketBeat.com.

Volatility and Risk

China Dongsheng International has a beta of 13.38, meaning that its stock price is 1,238% more volatile than the S&P 500. Comparatively, Affymax has a beta of 2.77, meaning that its stock price is 177% more volatile than the S&P 500.

Summary

China Dongsheng International beats Affymax on 1 of the 1 factors compared between the two stocks.

ARYx Therapeutics (OTCMKTS:ARYX) and China Dongsheng International (OTCMKTS:CDSG) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, profitability, risk, analyst recommendations, dividends and institutional ownership.

Analyst Recommendations

This is a summary of current recommendations for ARYx Therapeutics and China Dongsheng International, as reported by MarketBeat.

Risk and Volatility

ARYx Therapeutics has a beta of -0.53, suggesting that its stock price is 153% less volatile than the S&P 500. Comparatively, China Dongsheng International has a beta of 13.38, suggesting that its stock price is 1,238% more volatile than the S&P 500.

Valuation & Earnings

This table compares ARYx Therapeutics and China Dongsheng International's top-line revenue, earnings per share (EPS) and valuation.

Profitability

This table compares ARYx Therapeutics and China Dongsheng International's net margins, return on equity and return on assets.

Summary

China Dongsheng International beats ARYx Therapeutics on 1 of the 1 factors compared between the two stocks.

China Dongsheng International (OTCMKTS:CDSG) and AtheroNova (OTCMKTS:AHROQ) are both consumer staples companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, earnings, risk and dividends.

Analyst Ratings

This is a summary of current ratings and recommmendations for China Dongsheng International and AtheroNova, as reported by MarketBeat.com.

Profitability

This table compares China Dongsheng International and AtheroNova's net margins, return on equity and return on assets.

Volatility and Risk

China Dongsheng International has a beta of 13.38, suggesting that its share price is 1,238% more volatile than the S&P 500. Comparatively, AtheroNova has a beta of -8.71, suggesting that its share price is 971% less volatile than the S&P 500.

Earnings and Valuation

This table compares China Dongsheng International and AtheroNova's revenue, earnings per share (EPS) and valuation.

Summary

China Dongsheng International beats AtheroNova on 1 of the 1 factors compared between the two stocks.

China Botanic Pharmaceutical (OTCMKTS:CBPI) and China Dongsheng International (OTCMKTS:CDSG) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, valuation, risk, institutional ownership, earnings, analyst recommendations and dividends.

Risk and Volatility

China Botanic Pharmaceutical has a beta of 17.09, indicating that its stock price is 1,609% more volatile than the S&P 500. Comparatively, China Dongsheng International has a beta of 13.38, indicating that its stock price is 1,238% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for China Botanic Pharmaceutical and China Dongsheng International, as provided by MarketBeat.com.

Profitability

This table compares China Botanic Pharmaceutical and China Dongsheng International's net margins, return on equity and return on assets.

Valuation & Earnings

This table compares China Botanic Pharmaceutical and China Dongsheng International's gross revenue, earnings per share (EPS) and valuation.

Summary

China Botanic Pharmaceutical beats China Dongsheng International on 1 of the 1 factors compared between the two stocks.

China Health Industries (OTCMKTS:CHHE) and China Dongsheng International (OTCMKTS:CDSG) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, earnings, dividends and institutional ownership.

Volatility & Risk

China Health Industries has a beta of 1.67, meaning that its share price is 67% more volatile than the S&P 500. Comparatively, China Dongsheng International has a beta of 13.38, meaning that its share price is 1,238% more volatile than the S&P 500.

Valuation & Earnings

This table compares China Health Industries and China Dongsheng International's revenue, earnings per share and valuation.

China Health Industries has higher revenue and earnings than China Dongsheng International.

Profitability

This table compares China Health Industries and China Dongsheng International's net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of current ratings and target prices for China Health Industries and China Dongsheng International, as provided by MarketBeat.com.

Summary

China Health Industries beats China Dongsheng International on 4 of the 5 factors compared between the two stocks.